Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
- 31 May 2003
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 168 (1), 81-89
- https://doi.org/10.1016/s0021-9150(03)00025-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluationAtherosclerosis, 2002
- Risk factors and cardiovascular disease in TurkeyAtherosclerosis, 2001
- VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) TrialCirculation, 2000
- Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis.Circulation, 1999
- Atherogenicity of Triglyceride-Rich LipoproteinsThe American Journal of Cardiology, 1998
- Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Newly Diagnosed Exercise-Induced Myocardial Ischemia in Middle-Aged Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.JCI Insight, 1991
- Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and EAtherosclerosis, 1990
- Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.Circulation, 1990
- Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.JCI Insight, 1985